MMP-1, EGF, and IL-1B gene polymorphism can be associated with gastric carcinogenesis. However, no study has yet confirmed the definitive role of these gene polymorphisms in gastric cancer risk. The 194 gastric cancer patients, 94 gastric adenoma patients, and 182 controls were used in this study. The SNP of the MMP-1 promoter, EGF, and IL-1B-31 were analyzed by PCR-RFLP and sequencing. The genotype frequency was compared between cases and controls, and a univariate and multivariate analysis were performed to determine the significant risk factors associated with gastric adenoma and adenocarcinoma. The frequency of 1G/2G genotypes in the MMP-1 promoter was similar to those in controls (p=0.734). The frequency of A/G genotypes in the EGF was similar to those in controls (p=0.239). The frequency of C/T genotypes in the IL-1B-31 was similar to those in controls (p=0.239). According to univariate analysis, male sex (p＜0.0001), old age (≥60, p＜0.0001), atrophy (pepsinogen I/II ≤3, p＜0.0001), and G/G genotype of EGF (p=0.034) were significant risk factors associated with gastric adenoma and carcinoma. However, male sex (p=0.002), old age (p＜0.0001), and atrophy (p＜0.0001) were the only significant risk factors associated with gastric adenoma and carcinoma according to the multivariate analysis. In conclusion, the SNP of the MMP-1 promoter, EGF, and IL-1B-31 did not correlate with the risk of gastric adenoma and adenocarcinoma. Sex, age, and atrophy were the significant risk factors of gastric cancer.
Introduction
Gastric cancer, the forth most common cancer and the second leading cause of cancer death in the world, has high incidence and mortality, particularly in Japan and Korea. 1, 2 Gastric carcinogenesis is a multistep process in which genetic and environmental factors interact with each other. [3] [4] [5] [6] [7] Environmental factors, such as dietary habits, smoking, and helicobacter pylori infection are associated with higher risks of gastric cancer. [7] [8] [9] Alterations in various genes, including oncogenes, tumor-suppressor genes, DNA repair genes, cell-cycle-related genes and cell-adhesion-related genes, have been implicated in the course of gastric carcinogenesis. [10] [11] [12] Epidermal growth factor (EGF) activates multiple signaling pathways by binding with its receptor (EGFR), 13,14 resulting in the proliferation, differentiation and tumorigenesis of epithelial tissues. 15, 16 Recently, a research suggested that A-G polymorphism of EGF might be involved, not only in the occurrence, but also in the malignant progression of gastric cancer. 17 Matrix metalloproteinase-1 (MMP-1) plays a key role in cancer invasion and metastasis through the degradation of extracellular matrix (ECM) and basement membrane barriers. 18 Helicobacter pylori encoding the pathogenicity island activates MMP-1 in gastric epithelial cells via JNK and ERK. 19 The presence of 2G allele in the MMP-1 promotor has been reported to associate with the development and progression of colorecum cancer. 20 Hamajima et al 21 showed that the interleuking-1 
Assessment of prevalence of H. pylori infection
Serum anti-H. pylori antibody was measured using a commericial ELISA kit (Standard Diagnostics BIOLINE.
Kyonggi-do, Korea). Seropositivity for H. pylori antibody was defined by optical density values according to manufacturer's protocol.
Assessment of atrophy using serum pepsinogen level
Serum pepsinogen was measured using high-performance liquid chromatography. Serum pepsinogen status was defined as atrophic when the criteria of both serum pepsinogen I level ≤70 ng/ml and a pepsignogen I/II ratio (serum pepsinogen I (ng/ml)/serum pepsinogen II (ng/ml)) ≤3.0 were simultaneously fulfilled. 23 A p value of less than 0.05 was accepted as statistically significant.
Statistical analysis

Results
Baseline characteristics of study subjects
Baseline clinical characteristics of study subjects are summarized in Table 1 (Table 3) .
Discussion
We recently been reported to be associated with different levels of EGF production. 17 In the present study, the alleleic frequency of A/G genotypes in the EGF with gastric adenoma and carcinoma was similar to that in controls.
According to the univariate analysis, the G/G genotype of EGF was a significant risk factor associated with gastric adenoma and carcinoma, but the significance was absent in the multivariate analysis. Therefore, it seems that the presence of 2G allele of EGF did not increase the susceptibility for the development of gastric carcinoma, especially in the early stages. This discrepancy between our results and previous results will be due to small sample number and ethnic differences.
In the current study, there were no significant differences in the allelic frequency of IL-1B-31 among gastric adenoma, carcinoma and control. Recent meta-analysis showed that only the IL1RN×22 Genotype seems to consistently increase the risk of gastric precancerous lesions, supporting a role for this polymorphism in the early stages of gastric carcinogenesis. 25 Therefore, it seems that the presence of C/T genotypes in the IL-1B-31 did not increase the susceptibility for the development of gastric carcinoma, especially in early stages. This discrepancy between our results and previous results will be due to small sample number and ethnic differences.
In the present study, male sex (p=0.002), old age (p ＜0.0001), and atrophy (p＜0.0001) were the only significant risk factors associated with gastric adenoma and carcinoma according to the multivariate analysis.
These results indicate that the patients with these factors can be at a high risk group for the development of gastric cancer. High risk groups merit intensive gastric cancer screening.
In conclusion, the SNP of the MMP-1 promoter, EGF, and IL-1B-31 did not enhance the risk of gastric cancer. Sex, age, and atrophy were the only significant risk factors in the development of gastric cancer.
